What Are Untreated Loiasis Long-Term Complications?
At a Glance
Untreated loiasis can cause long-term kidney stress and rare heart damage due to chronic inflammation. While clearing the parasite halts organ damage, patients with high parasite loads require specialized, gradual treatments to safely clear the infection and avoid severe neurological reactions.
In this answer
4 sections
If you have lived with untreated Loa loa (African eye worm) for years, it is completely understandable to worry about lasting damage. Because this infection is often incorrectly considered a simple or “benign” eye issue, the hidden, systemic effects are frequently overlooked. The short answer is yes: long-term, high-burden loiasis can place stress on your kidneys and, in rare cases, affect your heart. However, successfully and safely clearing the parasite usually halts these damaging processes and prevents further deterioration.
Kidney Stress and Proteinuria
When Loa loa levels are very high—a condition known as a high microfilarial load, meaning there are many microscopic worms circulating in your blood—your kidneys have to constantly filter out the waste and immune complexes created by the infection. Over time, this chronic stress can lead to kidney impairment. This most commonly manifests as proteinuria (protein leaking into the urine) or hematuria (microscopic blood in the urine) [1][2].
Researchers believe this happens because the tiny filtering units of the kidneys, called glomeruli, become inflamed or damaged by the constant immune response [1][2]. Fortunately, simple, non-invasive tests like a routine urinalysis (urine dipstick) can help your doctor monitor your kidney function and detect these issues early.
Heart Issues and Eosinophilia
While much rarer than kidney stress, long-term untreated loiasis can theoretically impact the heart. This risk is driven by eosinophilia, a condition where your body produces abnormally high levels of eosinophils (a type of white blood cell) to fight off parasites [3].
When eosinophil levels remain severely elevated for years, the proteins they release can sometimes damage surrounding healthy tissues, including the heart muscle. In extreme cases, chronic hypereosinophilia from parasitic infections can lead to endomyocardial fibrosis (EMF), a condition where the heart muscle becomes stiff and scarred [4][5][6].
It is important to note that while this is a known risk of severe, chronic parasitic infections generally, direct cases of EMF caused solely by Loa loa are extremely rare [4]. If you are concerned about this complication, your doctor can order an echocardiogram (an ultrasound of the heart) to check for any structural changes.
Other Systemic Effects
Recent studies have also shown that chronic, high-load loiasis is associated with other systemic issues. For instance, it can lead to a reduction in spleen volume, potentially making the body more vulnerable to certain bacterial infections [7]. It is increasingly recognized that chronic, untreated loiasis is not a benign condition and can impact overall health and life expectancy if left ignored [8][5].
The Impact of Treatment (And Crucial Safety Warnings)
The most reassuring fact is that successfully treating the infection halts the underlying cause of this organ stress. Killing the parasites resolves the infection-associated immune abnormalities, allowing your eosinophil counts to drop and stopping the constant immune assault on your organs [9][2]. While evidence regarding the reversal of established cardiac or renal scarring is limited, eliminating the parasite effectively halts the progression of the damage [9][1].
Important Safety Warning for High-Burden Infections:
While treating the infection is essential to protect your organs, if you have a high microfilarial load, taking standard, fast-acting anti-parasitic medications (like diethylcarbamazine/DEC or ivermectin) is highly dangerous. When massive numbers of worms die off at once, it can trigger severe brain inflammation, known as encephalopathy, which can be fatal [10][11][12].
Because of this risk, high-burden infections require specialized, careful treatment protocols, ideally overseen by a tropical medicine or infectious disease specialist. To safely reduce the load, your care team might use:
Common questions in this guide
Can untreated loiasis damage my kidneys?
Does the African eye worm affect the heart?
Is it safe to treat a severe Loa loa infection quickly?
How can my doctor check for organ damage from loiasis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What was my exact microfilarial load on my most recent daytime blood test, and does that number put me at risk for severe treatment reactions?
- 2.Can we order a routine urinalysis to check for proteinuria or hematuria to assess my baseline kidney function?
- 3.Do my prolonged, highly elevated eosinophil levels warrant an echocardiogram to check for any signs of heart muscle stiffening?
- 4.Given my high parasite burden, what specialized, gradual treatment protocol (like albendazole or apheresis) will we use to safely lower the count before considering rapid-acting medications like DEC?
- 5.How many cases of high-burden Loiasis have you treated, and would it be safer for me to be referred to a tropical medicine or infectious disease specialist?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (13)
- 1
Association between blood Loa loa microfilarial density and proteinuria levels in a rural area of the Republic of Congo (the MorLo project): a population-based cross-sectional study.
Campillo JT, Hemilembolo MC, Pion SDS, et al.
The Lancet. Microbe 2023; (4(9)):e704-e710 doi:10.1016/S2666-5247(23)00142-8.
PMID: 37480932 - 2
Chronic kidney disease related to Loa loa microfilaremia in a rural area of the Republic of Congo: a population-based cross-sectional study.
Boullé C, Campillo JT, Hemilembolo MC, et al.
Infectious diseases of poverty 2025; (14(1)):88 doi:10.1186/s40249-025-01356-y.
PMID: 40841693 - 3
Loiasis in sub-Saharan migrants living in Spain with emphasis of cases from Equatorial Guinea.
Puente S, Ramírez-Olivencia G, Lago M, et al.
Infectious diseases of poverty 2020; (9(1)):16 doi:10.1186/s40249-020-0627-4.
PMID: 32029005 - 4
Atypical Clinical Manifestations of Loiasis and Their Relevance for Endemic Populations.
Buell KG, Whittaker C, Chesnais CB, et al.
Open forum infectious diseases 2019; (6(11)):ofz417 doi:10.1093/ofid/ofz417.
PMID: 31696139 - 5
Burden of disease in Gabon caused by loiasis: a cross-sectional survey.
Veletzky L, Hergeth J, Stelzl DR, et al.
The Lancet. Infectious diseases 2020; (20(11)):1339-1346 doi:10.1016/S1473-3099(20)30256-5.
PMID: 32585133 - 6
The African eye worm: current understanding of the epidemiology, clinical disease, and treatment of loiasis.
Ramharter M, Butler J, Mombo-Ngoma G, et al.
The Lancet. Infectious diseases 2024; (24(3)):e165-e178 doi:10.1016/S1473-3099(23)00438-3.
PMID: 37858326 - 7
Association between Loa loa microfilaremia and anatomical hyposplenia in a rural area of the Republic of Congo: a population-based cross-sectional study.
Boullé C, Lebredonchel E, Campillo JT, et al.
Infectious diseases of poverty 2025; (14(1)):8 doi:10.1186/s40249-025-01277-w.
PMID: 39923091 - 8
Excess mortality associated with loiasis: a retrospective population-based cohort study.
Chesnais CB, Takougang I, Paguélé M, et al.
The Lancet. Infectious diseases 2017; (17(1)):108-116 doi:10.1016/S1473-3099(16)30405-4.
PMID: 27777031 - 9
Infection-associated Immune Perturbations Resolve 1 Year Following Treatment for Loa loa.
Herrick JA, Makiya MA, Holland-Thomas N, et al.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2021; (72(5)):789-796 doi:10.1093/cid/ciaa137.
PMID: 32055862 - 10
Clinical Features of Imported Loiasis: A Case Series from the Hospital for Tropical Diseases, London.
Saito M, Armstrong M, Boadi S, et al.
The American journal of tropical medicine and hygiene 2015; (93(3)):607-11 doi:10.4269/ajtmh.15-0214.
PMID: 26101271 - 11
Albendazole-related Loa Loa encephalopathy.
Métais A, Michalak S, Rousseau A
IDCases 2021; (23()):e01033 doi:10.1016/j.idcr.2020.e01033.
PMID: 33489754 - 12
Loa loa Encephalopathy Following Treatment With Benzimidazole Derivatives: A Systematic Review.
Davi SD, Nordmann T, Endamne LR, et al.
Open forum infectious diseases 2025; (12(12)):ofaf700 doi:10.1093/ofid/ofaf700.
PMID: 41377593 - 13
Central and Peripheral Nervous System Disorders Following Ivermectin Mass Administration: A Descriptive Study Based on the Democratic Republic of Congo Pharmacovigilance System.
Nzolo D, Anto F, Hailemariam S, et al.
Drugs - real world outcomes 2017; (4(3)):151-158 doi:10.1007/s40801-017-0110-0.
PMID: 28600751
This page explains the potential long-term complications of untreated loiasis for educational purposes only. Always consult a tropical medicine or infectious disease specialist for diagnosis and to establish a safe treatment protocol.
Get notified when new evidence is published on Loiasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.